The quadrivalent human papillomavirus (HPV) vaccine worked as well for teens and young adults with HIV as it did for their HIV-negative counterparts, according to study findings presented the 20th International AIDS Conference last week in Melbourne.
Human papillomavirus is a common sexually transmitted infection that causes abnormal cell growth. High-risk strains, including type 16 and 18, can cause cervical and anal cancer. People typically become infected with HPV shortly after they become sexually active, regardless of HIV status. But HIV-positive people tend to harbour more HPV types, are less likely to spontaneously clear HPV and may experience faster disease progression from dysplasia (abnormal cell changes) to cancer.
Continue reading on aidsmap.com